(FILES) An employee walks between seats aboard an Airbus A320neo aircraft during a delivery event to low-cost carrier Transavia, in Toulouse, southwestern France, on January 10, 2024. Transavia, the low-cost carrier of the Air France-KLM group, will adjust its scheduled flight program for May and June 2026 to optimize its costs in response to the surge in kerosene prices linked to the war in the Middle East, a spokesperson told AFP on April 26, 2026, confirming a report by RMC. (Photo by Ed JONES / AFP via Getty Images)

(FILES) A low-cost Air France subsidiary Transavia plane flies over Nantes, western France, on April 13, 2026. Transavia, the low-cost carrier of the Air France-KLM group, will adjust its scheduled flight program for May and June 2026 to optimize its costs in response to the surge in kerosene prices linked to the war in the Middle East, a spokesperson told AFP on April 26, 2026, confirming a report by RMC. (Photo by Loic VENANCE / AFP via Getty Images)

(FILES) This photograph shows a Transavia Boeing 737-800 aircraft landing at Orly Airport, south of Paris, on April 6, 2026. Transavia, the low-cost carrier of the Air France-KLM group, will adjust its scheduled flight program for May and June 2026 to optimize its costs in response to the surge in kerosene prices linked to the war in the Middle East, a spokesperson told AFP on April 26, 2026, confirming a report by RMC. (Photo by Thomas SAMSON / AFP via Getty Images)

(FILES) A Boeing 737-8K2 of low-cost Air France subsidiary Transavia flies over Nantes, western France, on April 13, 2026. Transavia, the low-cost carrier of the Air France-KLM group, will adjust its scheduled flight program for May and June 2026 to optimize its costs in response to the surge in kerosene prices linked to the war in the Middle East, a spokesperson told AFP on April 26, 2026, confirming a report by RMC. (Photo by Loic VENANCE / AFP via Getty Images)

Sun Pharmaceutical Executive Chairman Dilip Shanghvi addresses a press conference in Mumbai on April 27, 2026. India's Sun Pharmaceutical on April 27 said it had agreed to buy women's healthcare firm Organon in a deal that values the US drugmaker at $11.75 billion. (Photo by Punit PARANJPE / AFP via Getty Images)

A man walks past the logo of Sun Pharmaceutical is pictured ahead of a press conference in Mumbai on April 27, 2026. India's Sun Pharmaceutical on April 27 said it had agreed to buy women's healthcare firm Organon in a deal that values the US drugmaker at $11.75 billion. (Photo by Punit PARANJPE / AFP via Getty Images)

The logo of Sun Pharmaceutical is pictured ahead of a press conference in Mumbai on April 27, 2026. India's Sun Pharmaceutical on April 27 said it had agreed to buy women's healthcare firm Organon in a deal that values the US drugmaker at $11.75 billion. (Photo by Punit PARANJPE / AFP via Getty Images)

Sun Pharmaceutical Executive Chairman Dilip Shanghvi addresses a press conference in Mumbai on April 27, 2026. India's Sun Pharmaceutical on April 27 said it had agreed to buy women's healthcare firm Organon in a deal that values the US drugmaker at $11.75 billion. (Photo by Punit PARANJPE / AFP via Getty Images)